Pharmaloz Manufacturing

Pharmaloz Manufacturing signed contracts with two top-tier lozenge brands, projected to add $5 million in annual revenue and over $1.25 million in yearly pre-tax net profits.

Pharmaloz Manufacturing, a subsidiary of ProPhase Labs, is expanding its plant capacity by over 50% through automation equipment and efficiencies, raising annual production capability from below $10 million to over $15 million.